Youngjoo Kwon Selected Research

Amyloid (Amyloid Fibrils)

1/2017	Luteolin as a potential preventive and therapeutic candidate for Alzheimer's disease.
4/2013	Effect of conjugated linoleic acid, μ-calpain inhibitor, on pathogenesis of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Youngjoo Kwon Research Topics

Disease

63	Neoplasms (Cancer) 04/2024 - 01/2007
13	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2007
6	Fibrosis (Cirrhosis) 01/2024 - 12/2008
5	Inflammation (Inflammations) 11/2022 - 05/2013
5	Ovarian Neoplasms (Ovarian Cancer) 02/2021 - 12/2015
5	Colonic Neoplasms (Colon Cancer) 01/2017 - 01/2004
4	Lung Neoplasms (Lung Cancer) 01/2023 - 08/2016
4	Carcinogenesis 01/2023 - 01/2004
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 12/2017
3	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 05/2012
3	Aberrant Crypt Foci 01/2007 - 01/2004
2	Triple Negative Breast Neoplasms 04/2024 - 01/2021
2	Non-alcoholic Fatty Liver Disease 01/2024 - 01/2022
2	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 10/2021
2	Cardiotoxicity 01/2023 - 05/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 11/2013
2	Stomach Neoplasms (Stomach Cancer) 01/2023 - 12/2012
2	Adenocarcinoma 12/2021 - 07/2014
2	Body Weight (Weight, Body) 07/2021 - 08/2009
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2021 - 06/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 01/2017
2	Hypersensitivity (Allergy) 01/2012 - 06/2011
1	Fatty Liver 01/2024
1	Nervous System Diseases (Neurological Disorders) 01/2023
1	Hypoxia (Hypoxemia) 01/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2021

Drug/Important Bio-Agent (IBA)

18	Type I DNA Topoisomerases (Topoisomerase I)IBA 03/2022 - 01/2010
16	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 01/2010
15	trioctyl phosphine oxide (TOPO)IBA 01/2023 - 01/2015
9	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 11/2013
9	pyridineIBA 12/2021 - 01/2010
8	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2023 - 02/2010
6	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2018 - 01/2007
4	PoisonsIBA 01/2023 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2010
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 05/2013
4	CurcuminIBA 08/2018 - 01/2004
4	PyridinesIBA 01/2016 - 05/2010
3	Amino Acids FDA Link 01/2024 - 01/2014
3	CalpainIBA 01/2023 - 04/2013
3	CytokinesIBA 11/2022 - 01/2016
3	LigandsIBA 11/2022 - 05/2013
3	HSP27 Heat-Shock ProteinsIBA 04/2021 - 08/2016
3	Peptides (Polypeptides)IBA 04/2013 - 06/2011
2	CollagenIBA 01/2024 - 12/2008
2	AntioxidantsIBA 01/2024 - 08/2018
2	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 10/2021
2	flavoneIBA 01/2023 - 01/2017
2	Trastuzumab (Herceptin)FDA Link 01/2023 - 06/2020
2	LuteolinIBA 11/2022 - 01/2017
2	Catechin (Z 7300)IBA 11/2022 - 08/2018
2	Gefitinib (Iressa)FDA Link 10/2022 - 04/2021
2	Estrogen ReceptorsIBA 06/2022 - 11/2014
2	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 10/2017
2	Mitogen-Activated Protein KinasesIBA 02/2021 - 01/2017
2	Bleomycin (Blenoxane)FDA LinkGeneric 08/2020 - 06/2020
2	ResveratrolIBA 08/2018 - 12/2008
2	sulforaphaneIBA 08/2018 - 01/2017
2	EnzymesIBA 04/2018 - 10/2016
2	CamptothecinIBA 06/2017 - 07/2014
2	Amyloid (Amyloid Fibrils)IBA 01/2017 - 04/2013
2	Neuroprotective AgentsIBA 10/2016 - 04/2013
2	Blood Glucose (Blood Sugar)IBA 04/2016 - 08/2009
2	Hydroxyl RadicalIBA 07/2015 - 05/2010
2	Tamoxifen FDA LinkGeneric 11/2014 - 10/2013
2	Conjugated Linoleic AcidsIBA 04/2013 - 12/2008
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 06/2007 - 01/2007
2	AzoxymethaneIBA 01/2007 - 01/2006
1	cathepsin SIBA 04/2024
1	Radiation-Sensitizing AgentsIBA 04/2024
1	BRCA1 ProteinIBA 04/2024
1	Choline (Choline Chloride)IBA 01/2024
1	Hyaluronic Acid (Hyaluronan)IBA 01/2024
1	BilirubinIBA 01/2024
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2024
1	ZM 241385 (ZM241385)IBA 01/2024
1	Adenosine (Adenocard)FDA LinkGeneric 01/2024
1	ChlorineIBA 01/2024
1	Androgen Antagonists (Antiandrogens)IBA 01/2023
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2023
1	enzalutamideIBA 01/2023
1	DNA-Activated Protein KinaseIBA 01/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2023
1	CalciumIBA 01/2023
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2023
1	FlavonoidsIBA 11/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2022
1	fisetinIBA 11/2022
1	Tyrosine Kinase InhibitorsIBA 10/2022
1	ErbB Receptors (EGF Receptor)IBA 10/2022
1	bisphenol AIBA 06/2022
1	AcidsIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	EstersIBA 01/2022
1	AndrogensIBA 10/2021

Therapy/Procedure

16	Therapeutics 01/2024 - 08/2010
7	Drug Therapy (Chemotherapy) 03/2022 - 06/2007
2	Castration 01/2023 - 10/2021